EARLY TRANSITION OF PERIPHERAL BLOOD WT1 MRNA LEVELS AFTER 5-AZACITIDINE PREDICTS HEMATOLOGICAL IMPROVEMENT IN PATIENTS WITH HIGHER RISK MDS

EHA Library, Shinpei Harada, 297896

A PROSPECTIVE MULTICENTER OPEN-LABEL STUDY OF THE EFFECTIVENESS OF EPOETIN BETA FOR PATIENTS WITH LOW/INTERMEDIATE-1-RISK (LOW/INT-1) MYELODYSPLASTIC SYNDROME (MDS): A-FINAL RESULTS

EHA Library, suporn Chuncharunee, 297897

A DYSMYELOPOIESIS IMMUNOPHENOTYPIC INDEX (DMI) AS AN INDEPENDENT PROGNOSTIC FACTOR FOR OVERALL SURVIVAL IN MDS PATIENTS.

EHA Library, Anargyros Symeonidis, 297898

A PHASE 1 STUDY TO EVALUATE THE EFFECTS OF RIFAMPIN, A STRONG CYP3A INDUCER, ON PHARMACOKINETICS OF PEVONEDISTAT IN PATIENTS WITH ADVANCED MALIGNANCIES

EHA Library, Xiaofei Zhou, 297899

A SPECIAL TYPE OF CHROMOSOME 1 ABNORMALITIES IN MYELODYSPLASTIC SYNDROME PATIENTS: DUPLICATION 1Q

EHA Library, Yan Yu, 297900

MULTICOLOR FLOW CYTOMETRY IN THE DIAGNOSIS OF MDS WITHOUT OBVIOUS MORPHOLOGICAL MYELODYSPLASTIC FEATURES

EHA Library, Yulia Davydova, 297901

LEUKEMIC TRANSFORMATION IN INTERMEDIATE 2 AND HIGH RISK MYELODYSPLASTIC SYNDROMES IN A REAL WORLD SETTING - A SINGLE INSTITUTION EXPERIENCE

EHA Library, Emil Aleksov, 297903

AZACITIDINE PROVIDES DURABLE RESPONSES AND IMPROVES OVERALL SURVIVAL-IN PATIENTS WITH CMML WITH INTERMEDIATE AND HIGH RISK CPSS SCORE- REAL WORLD DATA FROM 3 CENTRES ACROSS THE GLOBE.

EHA Library, Maria Ahmed, 297904

THE RELATIONSHIP OF RED CELL DISTRIBUTION WIDTH WITH PROGNOSTIC SCORING IN MYELODISPLASTIC SYNDROME

EHA Library, Ali Zahit Bolaman, 297905

DISTRIBUTION AND PROGNOSTIC INFLUENCE OF SF3B1 AND TP53 MUTATIONS IN MYELODYSPLASTIC SYNDROME IN COHORT OF SERBIAN PATIENTS

EHA Library, Natasa Colovic, 297906

ADDITIONAL EVENTS IN THE CLONAL EXPANSION OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA FOUND BY WHOLE-EXOME SEQUENCING

EHA Library, Fangfei Chen, 297907

CROVALIMAB FOR TREATMENT OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND COMPLEMENT C5 POLYMORPHISM – EXPERIENCE FROM THE COMPOSER PHASE I/II STUDY

EHA Library, Jun-ichi Nishimura, 297908

OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A 11-YEAR TERTIARY CENTER ANALYSIS

EHA Library, Selami Kocak Toprak, 297909

CLINICAL PROFILE OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) FROM A TERTIARY CARE CENTRE IN NORTH INDIA

EHA Library, Tribikram Panda, 297910

THE EXPERIENCE USING OF ELTROMBOPAG IN THE TREATMENT OF REFRACTORY TO IMMUNOSUPPRESSIVE THERAPY PATIENTS WITH APLASTIC ANEMIA.

EHA Library, Anastasia Abramova, 297911

A REAL-WORLD EXPERIENCE OF ELTROMBOPAG APPLICATION TO APLASTIC ANEMIA IN CHINA

EHA Library, Jing Ruan, 297912

HETEROGENEOUS GENETIC SPECTRUM OF CONGENITAL NEUTROPENIA IN KOREAN BY WHOLE EXOME SEQUENCING: VARIOUS GENETIC, PHENOTYPIC AND HISTOLOGIC FEATURES

EHA Library, Dajeong Jeong, 297913

INDIGENOUS EQUINE ANTITHYMOCYTE GLOBULIN, CYCLOSPORINE AND ELTROMBOPAG COMBINATION THERAPY IN THE TREATMENT OF SEVERE APLASTIC ANEMIA

EHA Library, Ragesh Radhakrishnan, 297914

GAUCHER DISEASE TYPE 1 PATIENTS TREATED WITH ELIGLUSTAT OVER 6 YEARS

EHA Library, ANDREIA FILIPA MARCOS MOREIRA, 297915

CTC1 MUTATION IN A PATIENT WITH BONE MARROW FAILURE

EHA Library, Şule Ünal, 297916

COMBINATION OF TWO RARE GENETIC DISEASES OF FANCONI APLASTIC ANEMIA AND 46,X,DEL(X)(Q23) IN A TURKISH GIRL

EHA Library, Alper Ozcan, 297917

HLA GENOTYPING IN JAPANESE PATIENT WITH MULTIPLE MYELOMA; AN EXPLORATORY BIOMARKER STUDY FOR PREDICTING RESPONSE AND TOXICITY OF MELPHALAN, PREDNISOLONE, AND BORTEZOMIB: AN ANCILLARY STUDY OF JCOG1105

EHA Library, Masaki Ri, 297918

HOMOHARRINGTONINE INDUCES APOPTOSIS OF MULTIPLE MYELOMA CELLS BY PROMOTING EXCESSIVE AUTOPHAGY VIA THE AMPK/MTOR SIGNALING PATHWAY

EHA Library, Xing Cui, 297919

COMPARATIVE ANALYSIS OF RNA VERSUS DNA AS INPUT MATERIAL FOR IGH REPERTOIRE SEQUENCING BASED DETECTION OF MULTIPLE MYELOMA

EHA Library, Artur Kowalik, 297920

SINGLE CELL PROTEOGENOMIC ANALYSIS ELUCIDATES TREATMENT OPTIONS AND A POTENTIAL THERAPEUTIC ESCAPE MECHANISM IN A MULTIPLE MYELOMA PATIENT

EHA Library, Jonathan Scolnick, 297921

DYSREGULATION OF LONG NON-CODING RNA IN MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA

EHA Library, Romana Bútová, 297922

THE STUDY ON THE EXPRESSION OF LONG NONCODING RNA IN MULTIPLE MYELOMA WITH EXTRAMEDULLARY DISEASE

EHA Library, Xiaoyan Qu, 297923

CD38+CD138+ CELLS IN BONE MARROW DETECTED BY FLOW CYTOMETRY AS AN ESSENTIAL FACTOR FOR THE RISK STRATIFICATION SYSTEM OF MULTIPLE MYELOMA

EHA Library, Rong Fu, 297924

ASSOCIATION BETWEEN METHYLATION STATUS OF SOX7, P15INK4B AND WNT PATHWAY ANTAGONIST GENES AND DEPTH OF RESPONSE IN MULTIPLE MYELOMA: A PILOT STUDY

EHA Library, Svetlana Svitina, 297925

RISK INDICATORS OF EARLY PROGRESSION OF MGUS INTO MULTIPLE MYELOMA IN RESIDENTS OF THE GOMEL REGION OF BELARUS

EHA Library, Zhanna Kozich, 297926

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN AL AMYLOIDOSIS: SURVIVAL RESULTS FROM A SINGLE CENTER

EHA Library, Mateusz Ziarkiewicz, 297927

DELETIONS AND AMPLIFICATIONS OF THE IGH VARIABLE AND CONSTANT REGIONS: A NOVEL PROGNOSTIC PARAMETER IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Hadas Rabani, 297928

DARA-VD VERSUS DARA-RD AS SALVAGE THERAPY FOR PATIENTS WITH MYELOMA.INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY RETE EMATOLOGICA PUGLIESE

EHA Library, Giuseppe Mele, 297929

SECOND AUTOGRAFT OUTCOME IN RELAPSED MULTIPLE MYELOMA : A FRENCH MULTICENTRIC COHORT.

EHA Library, Axel André, 297930

THE ROLE OF ABERRANT, COMPLEX KARYOTYPES, DOUBLE-HIT ABNORMALITIES AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Andrei Garifullin, 297931

INFLUENCE OF STATIN THERAPY ON GALECTIN-3, VASCULAR ENDOTHELIAL GROWTH FACTOR, AND CARDIOVASCULAR RISK IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Borys Samura, 297932

EFFICACY OF POLYCHEMOTHERAPY IN TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA IN THE AGE OF NEW AGENTS

EHA Library, Xabier Gutiérrez Lopez de Ocáriz, 297933

LIGHTHOUSE (OP-108): A PHASE 3 STUDY OF MELFLUFEN IN COMBINATION WITH DARATUMUMAB VERSUS DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, María-Victoria Mateos, 297934

HEALTH-RELATED QUALITY OF LIFE OUTCOMES FROM THE PHASE 3 CANDOR STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Katja Weisel, 297935

PROGNOSTIC IMPACT OF RAPID REDUCTION OF INVOLVED FREE LIGHT CHAINS DURING FIRST LINE THERAPY WITH BENDAMUSTINE, PREDNISONE AND BORTEZOMIB (BPV) IN MYELOMA PATIENTS

EHA Library, Tanja Holzhey, 297936

A RETROSPECTIVE OBSERVATIONAL STUDY OF THE TREATMENT OF MULTIPLE MYELOMA IN ROUTINE CLINICAL PRACTICE IN NORTH ESTONIAN MEDICAL CENTER 2009 - 2016.

EHA Library, Liva Andersone, 297937

MULTIPLE MYELOMA IN PORTUGAL: INCIDENCE, PREVALENCE, MORTALITY AND TREATMENT PATTERN

EHA Library, RUI FILIPE BERGANTIM, 297938

A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PROGRESSION-FREE SURVIVAL BETWEEN ELOTUZUMAB, DARATUMUMAB, AND PANOBINOSTAT TRIPLET REGIMENS FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Clara Chen, 297939

QUANTIFICATION OF HEAVY + LIGHT CHAIN PAIRS AS POTENTIAL TECHNIQUE FOR QUICK AND ACCURATE MULTIPLE MYELOMA RESPONSE ASSESSMENT: A PROSPECTIVE STUDY

EHA Library, Karla Vallejo, 297940

RDW IS A PROGNOSTIC FACTOR IN AUTOLOGOUS STEM CELL TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

EHA Library, Susana Gonçalves Pereira, 297942

RENAL AND CARDIAC TOXICITY ASSOCIATED WITH CARFILZOMIB TREATMENT IN RRMM.

EHA Library, Stephanie Guidez, 297943

REAL LIFE EFFECTIVENESS OF VENETOCLAX BASED THERAPY IN HEAVILY PRE-TREATED PATIENTS WITH PLASMA CELL DYSCRASIA

EHA Library, Efrat Luttwak, 297944

THE MYELOMA LANDSCAPE IN AUSTRALIA AND NEW ZEALAND (ANZ): THE FIRST SEVEN YEARS OF THE MYELOMA AND RELATED DISEASES REGISTRY (MRDR)

EHA Library, Krystal Bergin, 297945

THROMBOEMBOLIC DISEASE INCIDENCE IN MULTIPLE MYELOMA PATIENTS.RETROSPECTIVE EXPERIENCE OF 2 SPANISH CENTERS.

EHA Library, Luis Miguel Juárez-Salcedo, 297946

NON-INVASIVE AND AFFORDABLE FIRST-STEP DIAGNOSTIC TEST FOR THE EARLY DIAGNOSIS OF GAUCHER’S DISEASE IN PATIENTS WITH MONOCLONAL GAMMAPATHIES (MGUS OR MYELOMA): MONOCENTRIC OBSERVATIONAL STUDY

EHA Library, Giuseppe Mele, 297947

THERAPY REGIMENS INCLUDING DARATUMUMAB FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: REPORT FROM THE MULTIPLE MYELOMA GIMEMA LAZIO GROUP

EHA Library, Francesca Fazio, 297948

REAL LIFE DATA OF PROGNOSTIC MINIMAL RESIDUAL DISEASE EVALUATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

EHA Library, ROSSELLA RIBOLLA, 297949

MULTIPLE MYELOMA WITH FISH-IDENTIFIED TP53 DELETION: A REAL-WORLD EXPERIENCE OF 103 PATIENTS

EHA Library, András Kozma, 297950

CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA

EHA Library, Claudio Cerchione, 297951

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN MULTIPLE MYELOMA IN THE ASIA-PACIFIC REGION: PRELIMINARY RESULTS OF THE ASIA-PACIFIC MYELOMA AND RELATED DISEASES REGISTRY

EHA Library, Andrew Spencer, 297952

IMPACT OF OVERALL POPULATION HEALTH ON SURVIVAL IN MULTIPLE MYELOMA

EHA Library, Lewis McCheyne, 297953

DREAMM-9: PHASE III STUDY OF BELANTAMAB MAFODOTIN PLUS VRD VS. VRD ALONE IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (TI NDMM)

EHA Library, Saad Z. Usmani, 297954

ADVERSE EVENT AND OUTCOME PATTERNS IN PATIENTS WITH ADVANCED MULTIPLE MYELOMA IN THE US

EHA Library, Joshua Richter, 297955

“REAL WORLD” BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE COMBINATION IN TRANSPLANT INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Helene Gardeney, 297956

DREAMM-3: PHASE III, OPEN-LABEL, RANDOMIZED STUDY OF SINGLE-AGENT BELANTAMAB MAFODOTIN VERSUS POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE (POM/DEX) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Katja Weisel, 297957

TREATMENT RESPONSE WITHOUT TWO CONSECUTIVE ASSESSMENTS OF TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: A SUPPLEMENTARY ANALYSIS OF JCOG1105

EHA Library, Nobuhiko Nakamura, 297958

CHANGES IN THE TREATMENT LANDSCAPE OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND THEIR ASSOCIATION WITH MORTALITY: INSIGHTS FROM A LARGE GERMAN CLAIMS DATABASE

EHA Library, CHRISTOF SCHEID, 297959

PREDICTORS OF RENAL RECOVERY IN PATIENTS OF NEWLY DIAGNOSED MULTIPLE MYELOMA PRESENTING WITH RENAL IMPAIREMENT IN REAL WORLD

EHA Library, RINTU SHARMA, 297960

PATIENT SIMILARITY ANALYSIS AND VISUALIZATION IN MULTIPLE MYELOMA

EHA Library, Joanne Joseph, 297961

IDENTIFICATION OF DYNAMIC BIOMARKERS OF RESPONSE TO PANOBINOSTAT CONSOLIDATION IN MM PATIENTS WITH A SUBOPTIMAL RESPONSE FOLLOWING UPFRONT ASCT (PANO-MONO STUDY)

EHA Library, Anna Kalff, 297962

SIGNIFICANCE OF PROGNOSTIC EVALUATION BASED ON TREATMENT EFFECT AT 6 MONTHS IN LENALIDOMIDE PLUS DEXAMETHASONE THERAPY

EHA Library, Naoki Takezako, 297963

PROGRESSIVE RELAPSES ARE ASSOCIATED WITH SHORTER TTNT AND PFS IN MULTIPLE MYELOMA PATIENTS IN AN ASIAN POPULATION

EHA Library, Cinnie Soekojo, 297964

BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN HEAVILY PRETREATED MULTIPLE MYELOMA: OLD/NEW IN NOVEL AGENTS' ERA

EHA Library, Claudio Cerchione, 297965

REAL-WORLD, MULTI-CENTRE REVIEW OF THE EFFECTIVENESS OF DARA MONOTHERAPY AND PATIENTS’ RESPONSE TO SUBSEQUENT THERAPIES

EHA Library, Matthew Holt, 297966

VENETOCLAX PLUS BORTEZOMIB AND DEXAMETHASONE IN HEAVILY PRETREATED END-STAGE MYELOMA PATIENTS WITHOUT T(11;14): A REAL-WORLD COHORT

EHA Library, Tomas Jelínek, 297967

HOW TO PREVENT PNEUMONIAS IN PATIENTS WITH MULTIPLE MYELOMA ON NOVEL AGENTS: THE NEW REGIMEN OF PNEUMOCOCCAL VACCINATION

EHA Library, Igor Stoma, 297968

EXPERIENCE WITH THE USE OF ANTITUMOR PROGRAMS OF VMP (BORTEZOMIB, MELPHALANE, PREDNISOLONE) AND RVP (LENALIDOMIDE, BORTEZOMIB, PREDNISOLONE) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Кирилл Белоусов, 297969

CLINICO-PATHOLOGICAL PROFILE AND TREATMENT OUTCOME OF MULTIPLE MYELOMA: FIRST REPORT FROM QATAR

EHA Library, Hesham El Sabah, 297970

OPEN-LABEL PILOT STUDY OF GENETICALLY ENGINEERED NY-ESO-1–SPECIFIC T CELLS (GSK3377794) ALONE OR IN COMBINATION WITH PEMBROLIZUMAB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Jonathan L Kaufman, 297971

BORTEZOMIB BASED CHEMOTHERAPY FOR INDUCTION THERAPY FOLLOWED BY IXAZOMIB-DEXAMETHASONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Man Shen, 297972

CARFILZOMIB-RELATED LONG TERM CARDIAC TOXICITIES IN ASYMPTOMATIC PATIENTS.

EHA Library, Veronica Mattiello, 297973

LIGHT-CHAIN AMYLOIDOSIS IN LATIN AMERICA. DIAGNOSIS AND FRONTLINE TREATMENT.

EHA Library, Eloísa Riva, 297974

CLINICAL IMPACT OF SPINE MRI AS A VALUABLE PROGNOSTIC TOOL FOR PATIENTS WITH NEWLY DIAGNOSED WITH MULTIPLE MYELOMA

EHA Library, Dong Won Baek, 297975

REAL LIFE USE AND OUTCOMES OF POMALIDOMIDE BASED ANTI-MYELOMA THERAPIES AN ANALYSIS FROM THE AUSTRIAN MYELOMA REGISTRY (AMR)

EHA Library, Eva Wallner, 297976

VARIETIES OF THE EXTRAMEDULLARY PLASMA CELL NEOPLASIA: CLINICAL FEATURES AND PROGNOSTIC IMPACT

EHA Library, Vladislava Djurasinovic, 297977

MULTIPLE MYELOMA IN REAL-WORLD CLINICAL PRACTICE: IMPACT OF TRANSPLANT ON SURVIVAL

EHA Library, AHMAD ALGHOCHE, 297978

ANALYZING THE STATUS OF HEMATOLOGIC MALIGNANCIES IN KOREA USING 2005-2015 NATIONAL HEALTH INSURANCE DATA; STATUS OF PROGRESS FROM MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE TO MULTIPLE MYELOMA

EHA Library, Min Jin Kim, 297979

DREAMM-1: PATIENT PERSPECTIVES FROM THE FIRST-IN-HUMAN STUDY OF SINGLE-AGENT BELANTAMAB MAFODOTIN FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Laurie Eliason, 297980

DREAMM-5 PLATFORM TRIAL: BELANTAMAB MAFODOTIN IN COMBINATION WITH NOVEL AGENTS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, PAUL RICHARDSON, 297981

PROSPECTIVE ANALYSIS OF AMYLOIDOSIS INCIDENCE IN THE UNIVERSITY TEACHING HOSPITAL IN WROCŁAW – SINGLE CENTRE EXPERIENCE

EHA Library, Magdalena Olszewska-Szopa, 297982

CHRONIC KIDNEY DISEASE AND RESPIRATORY PATHOLOGY AS A PREDICTOR OF INFECTIOUS COMPLICATIONS OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Evgeniy Mikhailov, 297983

CLINICAL PROFILE AND TREATMENT OUTCOMES OF AL AMYLOIDOSIS PATIENTS WITH CARDIAC INVOLVEMENT

EHA Library, Aditya Jandial, 297984

RECOMBINANT HUMAN THROMBOPOIETIN MAY ACCELERATE BONE MARROW HEMATOPOIETIC RECONSTRUCTION IN AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA IN NOVEL-AGENT ERA

EHA Library, Guangzhong Yang, 297985

OUTCOMES OF MAINTENANCE THERAPY USING LENALIDOMIDE OR BORTEZOMIB IN MULTIPLE MYELOMA PATIENTS POST AUTOLOGUS STEM CELL TRANSPLANTATION

EHA Library, Haitham Abdelbary, 297986

TREATMENT PATTERNS AND CLINICAL OUTCOMES IN NON-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) IN SPAIN

EHA Library, Dasha Cherepanov, 297987

EFFECTIVENESS OF HEMADSORPTION IN REDUCING FREE LIGHT CHAINS IN PATIENTS WITH MULTIPLE MYELOMA.

EHA Library, Aleksandr Fomin, 297988

THIRTY-FIVE CASES OF WALDENSTRÖM MACROGLOBULINEMIA: TEN YEARS’EXPERIENCE FROM A SINGLE CENTER.

EHA Library, Silvia Garcia Canales, 297989

CLINICOPATHOLOGIC SPECTRUM OF WALDENSTROM’S MACROGLOBULINEMIA: A SINGLE CENTER EXPERIENCE

EHA Library, Sanjeev Yadav, 297990

HIGH-DOSE VS STANDARD THERAPY IN PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA AGED 65-75 YEARS: A RETROSPECTIVE ANALYSIS

EHA Library, Massimo Offidani, 297991

DYNAMIC ASSESSMENT OF THE PROGRESSION RISK OF MGUS PATIENTS BASED ON FREE LIGHT CHAINS AND HEAVY LIGHT CHAINS BIOMARKERS

EHA Library, Tiago Pais, 297992

CBD REGIMEN PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT FOLLOWED BY WEEKLY BD CONSOLIDATION AND RD MAINTENANCE FOR NEWLY DIAGNOSED MULTIPLE MYELOMA; PHASE Ⅱ STUDY OF NBMTG ASCT1201

EHA Library, Naoto Imoto, 297993

MONOCLONAL IMMUNOGLOBULINS PROGNOSTIC SIGNIFICANCE FOR THE EVALUATION OF SENSITIVITY TO LENALIDOMIDE-DEXAMETHASONE (RD) TREATMENT

EHA Library, Annita-Ioanna Gkioka, 297994

CLINICAL PROFILE OF MULTIPLE MYELOMA PATIENTS WITH LONG TERM SURVIVAL

EHA Library, Marta Raimondo, 297995

MULTIPLE MYELOMA WITH AND WITHOUT EXTRAMEDULLARY INVOLVEMENT: COMPARATIVE STUDY OF EPIDEMIOLOGIC, RADIOLOGICALY, THERAPEUTIC AND OUTCOME CHARACTERISTICS

EHA Library, Malek Sayadi, 297996

СYTOGENETIC STUDY OF BONE MARROW IN PATIENTS WITH MULTIPLE MYELOMA IN THE REAL CLINICAL PRACTICE (RESULTS OF RUSSIAN MULTICENTER STUDY)

EHA Library, Maxim Solovev, 297997